Table 2.
Laboratory findings in 90 patients with COVID-19 at admission.
| Total | Non-severe | Severe | ||
|---|---|---|---|---|
| Laboratory finding | (n = 90) | (n = 70) | (n = 20) | p-value |
| WBCs, × 109/L | 5.95 ± 2.58 | 5.57 ± 1.56 | 7.27 ± 4.46 | 0.008 |
| Neutrophil count, × 109/L | 3.32 (2.48–4.31) | 3.24(2.47–4.18) | 3.88(2.76–9.97) | 0.093 |
| Lymphocyte count, × 109/L | 1.30 (0.89–1.86) | 1.50(1.08–2.05) | 0.63(0.48–1.12) | <0.001 |
| Monocyte count, × 109/L | 0.34 (0.27–0.48) | 0.34(0.28–0.48) | 0.35(0.24–0.46) | 0.927 |
| Hemoglobin, g/L | 134.50 (123.00–144.00) | 135.00 (123.00–144.00) | 133.00 (126.00–144.50) | 0.900 |
| Platelet count, × 109/L | 189.50 (143.00–248.00) | 209.00 (159.00–259.00) | 165.00 (125.00–178.00) | 0.003 |
| APTT, s | 26.80 (24.80–30.30) | 26.70 (24.90–30.30) | 28.00 (23.55–32.60) | 0.917 |
| PT, s | 11.50 (10.80–12.00) | 11.40 (10.70–11.90) | 11.85 (11.30–12.55) | 0.051 |
| D-dimer, ug/mL.FEU | 0.46 (0.19–1.00) | 0.38 (0.16–0.73) | 1.60 (0.51–3.12) | <0.001 |
| Fibrinogen, g/L | 2.44 (2.12–3.11) | 2.30 (2.10–2.68) | 3.15 (2.64–3.89) | <0.001 |
| CRP, mg/dL | 0.36 (0.08–3.68) | 0.17 (0.06–0.95) | 6.28 (2.49–10.49) | <0.001 |
| Procalcitonin, ng/mL | 0.05 (0.04–0.10) | 0.04 (0.04–0.06) | 0.17 (0.08–0.45) | <0.001 |
| LDH, U/L | 186.00 (138.00–223.00) | 160.00 (134.00–200.00) | 220.50 (188.00–364.50) | <0.001 |
| PaO2/FiO2, mmHg | 345.50 (301.00–381.00) | 355.00 (336.00–394.00) | 216.00 (197.50–260.00) | <0.001 |
The data are shown as median value (interquartile range).
Abbreviations: WBC white blood cell; APTT activated partial thromboplastin time; PT prothrombin time; CRP C-reactive protein; LDH lactate dehydrogenase.